Literature DB >> 27437987

Transcranial low-level infrared laser irradiation ameliorates depression induced by reserpine in rats.

Haitham S Mohammed1.   

Abstract

Transcranial low-level infrared laser is a modality of therapy based on the principle of photons delivered in a non-invasive manner through the skull for the treatment of some neurological conditions such as psychological disorders, traumatic brain injuries, and neurodegenerative diseases among others. In the present study, effects of low-level infrared laser irradiation with different radiation powers (80, 200, and 400 mW, continuous wave) were investigated on normal animals subjected to forced swimming test (FST). Results indicated that there are changes in FST parameters in animals irradiated with laser; the lowest dose provoked a significant increase in animal activity (swimming and climbing) and a significant decrease in animal's immobility, while the highest laser dose resulted in a complete inverse action by significantly increasing animal immobility and significantly decreasing animal activity with respect to control animals. The lowest dose (80 mW) of transcranial laser irradiation has then utilized on animals injected with a chronic dose of reserpine (0.2 mg/kg i.p. for 14 days) served as an animal model of depression. Laser irradiation has successfully ameliorated depression induced by reserpine as indicated by FST parameters and electrocorticography (ECoG) spectral analysis in irradiated animals. The findings of the present study emphasized the beneficial effects of low-level infrared laser irradiation on normal and healthy animals. Additionally, it indicated the potential antidepressant activity of the low dose of infrared laser irradiation.

Entities:  

Keywords:  Depression; ECoG; FST; Low-level infrared laser; Rat

Mesh:

Substances:

Year:  2016        PMID: 27437987     DOI: 10.1007/s10103-016-2033-5

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  31 in total

1.  A pharmaco-EEG study of the interaction between ethanol and retigabine in rabbits.

Authors:  Ewa Zwierzyńska; Agata Krupa; Bogusława Pietrzak
Journal:  Am J Drug Alcohol Abuse       Date:  2015-02-10       Impact factor: 3.829

2.  Biphasic dose response in low level light therapy.

Authors:  Ying-Ying Huang; Aaron C-H Chen; James D Carroll; Michael R Hamblin
Journal:  Dose Response       Date:  2009-09-01       Impact factor: 2.658

3.  Reserpine as an uncoupling agent.

Authors:  G Mania
Journal:  Biochim Biophys Acta       Date:  1974-03-26

Review 4.  Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis.

Authors:  Paolo Cassano; Samuel R Petrie; Michael R Hamblin; Theodore A Henderson; Dan V Iosifescu
Journal:  Neurophotonics       Date:  2016-03-04       Impact factor: 3.593

Review 5.  A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013.

Authors:  David A Mrazek; John C Hornberger; C Anthony Altar; Irina Degtiar
Journal:  Psychiatr Serv       Date:  2014-08-01       Impact factor: 3.084

6.  Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates.

Authors:  M Olga Rojas-Corrales; Esther Berrocoso; Juan Gibert-Rahola; Juan Antonio Micó
Journal:  J Psychopharmacol       Date:  2004-09       Impact factor: 4.153

7.  Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.

Authors:  Andrew F Leuchter; Ian A Cook; William S Gilmer; Lauren B Marangell; Karl S Burgoyne; Robert H Howland; Madhukar H Trivedi; Sidney Zisook; Rakesh Jain; Maurizio Fava; Dan Iosifescu; Scott Greenwald
Journal:  Psychiatry Res       Date:  2009-08-26       Impact factor: 3.222

8.  Depressive-like symptoms in a reserpine-induced model of fibromyalgia in rats.

Authors:  Arantxa Blasco-Serra; Francesc Escrihuela-Vidal; Eva M González-Soler; Fernando Martínez-Expósito; M Carmen Blasco-Ausina; Sergio Martínez-Bellver; Ana Cervera-Ferri; Vicent Teruel-Martí; Alfonso A Valverde-Navarro
Journal:  Physiol Behav       Date:  2015-07-26

9.  Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia.

Authors:  Yukinori Nagakura; Tomoya Oe; Toshiaki Aoki; Nobuya Matsuoka
Journal:  Pain       Date:  2009-07-30       Impact factor: 6.961

10.  Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

Authors:  Christina D Chambers; Sonia Hernandez-Diaz; Linda J Van Marter; Martha M Werler; Carol Louik; Kenneth Lyons Jones; Allen A Mitchell
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245

View more
  9 in total

1.  Investigating the transmission profiles of 808 nm laser through different regions of the rat's head.

Authors:  Omnia Hamdy; Haitham S Mohammed
Journal:  Lasers Med Sci       Date:  2020-07-08       Impact factor: 3.161

Review 2.  Brain Photobiomodulation Therapy: a Narrative Review.

Authors:  Farzad Salehpour; Javad Mahmoudi; Farzin Kamari; Saeed Sadigh-Eteghad; Seyed Hossein Rasta; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

3.  Synergistic effects of combined therapy with transcranial photobiomodulation and enriched environment on depressive- and anxiety-like behaviors in a mice model of noise stress.

Authors:  Javad Mahmoudi; Seyed Hossein Rasta; Narmin Farazi; Saeed Sadigh-Eteghad; Fereshteh Farajdokht
Journal:  Lasers Med Sci       Date:  2021-08-25       Impact factor: 3.161

4.  Antidepressant and antioxidant effects of transcranial irradiation with 830-nm low-power laser in an animal model of depression.

Authors:  Haitham S Mohammed; Yasser A Khadrawy
Journal:  Lasers Med Sci       Date:  2021-09-06       Impact factor: 3.161

5.  Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: reduction in oxidative stress, neuroinflammation, and apoptosis.

Authors:  Farzad Salehpour; Fereshteh Farajdokht; Paolo Cassano; Saeed Sadigh-Eteghad; Marjan Erfani; Michael R Hamblin; Maryam Moghadam Salimi; Pouran Karimi; Seyed Hossein Rasta; Javad Mahmoudi
Journal:  Brain Res Bull       Date:  2018-10-29       Impact factor: 4.077

Review 6.  Current application and future directions of photobiomodulation in central nervous diseases.

Authors:  Muyue Yang; Zhen Yang; Pu Wang; Zhihui Sun
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

Review 7.  Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation.

Authors:  Luodan Yang; Hannah Youngblood; Chongyun Wu; Quanguang Zhang
Journal:  Transl Neurodegener       Date:  2020-06-01       Impact factor: 8.014

8.  Transcranial Laser Therapy Does Not Improve Cognitive and Post-Traumatic Stress Disorder-Related Behavioral Traits in Rats Exposed to Repetitive Low-Level Blast Injury.

Authors:  Georgina Perez Garcia; Gissel M Perez; Alena Otero-Pagan; Rania Abutarboush; Usmah Kawoos; Rita De Gasperi; Miguel A Gama Sosa; Dylan Pryor; Patrick R Hof; David G Cook; Sam Gandy; Stephen T Ahlers; Gregory A Elder
Journal:  Neurotrauma Rep       Date:  2021-12-02

9.  Variations in tissue optical parameters with the incident power of an infrared laser.

Authors:  Omnia Hamdy; Haitham S Mohammed
Journal:  PLoS One       Date:  2022-01-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.